麻酔薬の世界市場レポート2024-2030

英文タイトル: Global Anesthesia Drugs Market Insights, Forecast to 2030

麻酔薬の世界市場レポート2024-2030
  • レポートID:247932
  • 発表時期:2024-08-26
  • 訪問回数:134
  • ページ数:147
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:160
  • レポートカテゴリ: 薬品及びサプリメント

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は、麻酔薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に麻酔薬市場を分類しています。

本レポートでは世界の麻酔薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Aspen Pharma、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Yichang Humanwell、Nhwa、Hengrui、Xi'an Libang

レポートは麻酔薬の主要生産者を調査し、主要地域や国の消費状況も提供します。麻酔薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント:
Propofol
Sevoflurane
Local Anesthesia
Other

用途別の市場セグメント:
Injection Anesthetics
Inhalational Anesthetics
Other

レポートの詳細内容
本レポートは、世界の麻酔薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて麻酔薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)の麻酔薬生産量、成長率、市場シェアを調査している。

二. 消費面では、麻酔薬の売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの麻酔薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の麻酔薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本麻酔薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

1章:麻酔薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(20192030
2章: 麻酔薬の世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(20192030
3章:世界、地域、国レベルにおける麻酔薬の売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(20192030
4麻酔薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(20192024
5章:麻酔薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(20192030
7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(20192030
8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(20192030
9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(20192030
10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(20192030
11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(20192030
12章:麻酔薬の主要メーカーの概要を提供し、製品の説明と仕様、麻酔薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(20192024
13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
14章:麻酔薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
15章:レポートの要点と結論。

biaoTi

概要

Anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries. Anesthesia drugs are medications used to induce a state of controlled unconsciousness or to block sensation in specific areas of the body during medical procedures. They are classified into various types based on their effects and administration routes. General anesthetics, such as propofol and sevoflurane, induce a deep sleep-like state across the entire body, allowing for pain-free surgical procedures. Local anesthetics, such as lidocaine and bupivacaine, block sensation in a targeted area, providing pain relief for minor surgeries or dental work. Regional anesthetics, like epidurals and spinals, affect larger areas of the body by blocking nerve signals in a specific region. These drugs are essential in modern medicine, ensuring that patients undergo procedures with minimal discomfort and risk.
The global Anesthesia Drugs market is projected to grow from US$ 7873 million in 2024 to US$ 9911 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
Global key players of Anesthesia Drugs include Yichang Humanwell, Fresenius-Kabi, Hengrui, Aspen Pharma, Nhwa, etc. The top five players hold a share about 45%. Asia-Pacific is the largest market, and has a share about 39%, followed by North America and Europe with share 25% and 22%, separately. In terms of product type, Local Anesthesia is the largest segment, accounting for a share of 48%. In terms of application, Injection Anesthetics is the largest field with a share about 59 percent.
Report Includes
This report presents an overview of global market for Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anesthesia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anesthesia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, etc.
Market Segmentation
By Company
    Aspen Pharma
    Fresenius-Kabi
    AbbVie
    Baxter Healthcare
    B.Braun
    Maruishi
    Piramal
    Hikma Pharmaceuticals
    Yichang Humanwell
    Nhwa
    Hengrui
    Xi'an Libang

Segment by Type
    Propofol
    Sevoflurane
    Local Anesthesia
    Other

Segment by Application
    Injection Anesthetics
    Inhalational Anesthetics
    Other

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
biaoTi

総目録

1 Study Coverage
1.1 Anesthesia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Local Anesthesia
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Injection Anesthetics
1.3.3 Inhalational Anesthetics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Anesthesia Drugs Revenue Estimates and Forecasts 2019-2030
2.2 Global Anesthesia Drugs Revenue by Region
2.2.1 Global Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Anesthesia Drugs Revenue by Region (2019-2024)
2.2.3 Global Anesthesia Drugs Revenue by Region (2025-2030)
2.2.4 Global Anesthesia Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Anesthesia Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Anesthesia Drugs Sales by Region
2.4.1 Global Anesthesia Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Anesthesia Drugs Sales by Region (2019-2024)
2.4.3 Global Anesthesia Drugs Sales by Region (2025-2030)
2.4.4 Global Anesthesia Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers
3.1 Global Anesthesia Drugs Sales by Manufacturers
3.1.1 Global Anesthesia Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anesthesia Drugs in 2023
3.2 Global Anesthesia Drugs Revenue by Manufacturers
3.2.1 Global Anesthesia Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anesthesia Drugs Revenue in 2023
3.3 Global Key Players of Anesthesia Drugs, Industry Ranking, 2021 VS 2022
3.4 Global Anesthesia Drugs Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anesthesia Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Anesthesia Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anesthesia Drugs Sales by Type
4.1.1 Global Anesthesia Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Anesthesia Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Anesthesia Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anesthesia Drugs Revenue by Type
4.2.1 Global Anesthesia Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Anesthesia Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Anesthesia Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anesthesia Drugs Price by Type
4.3.1 Global Anesthesia Drugs Price by Type (2019-2024)
4.3.2 Global Anesthesia Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Anesthesia Drugs Sales by Application
5.1.1 Global Anesthesia Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Anesthesia Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Anesthesia Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anesthesia Drugs Revenue by Application
5.2.1 Global Anesthesia Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Anesthesia Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Anesthesia Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anesthesia Drugs Price by Application
5.3.1 Global Anesthesia Drugs Price by Application (2019-2024)
5.3.2 Global Anesthesia Drugs Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Anesthesia Drugs Market Size by Type
6.1.1 US & Canada Anesthesia Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Anesthesia Drugs Revenue by Type (2019-2030)
6.2 US & Canada Anesthesia Drugs Market Size by Application
6.2.1 US & Canada Anesthesia Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Anesthesia Drugs Revenue by Application (2019-2030)
6.3 US & Canada Anesthesia Drugs Market Size by Country
6.3.1 US & Canada Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Anesthesia Drugs Revenue by Country (2019-2030)
6.3.3 US & Canada Anesthesia Drugs Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Anesthesia Drugs Market Size by Type
7.1.1 Europe Anesthesia Drugs Sales by Type (2019-2030)
7.1.2 Europe Anesthesia Drugs Revenue by Type (2019-2030)
7.2 Europe Anesthesia Drugs Market Size by Application
7.2.1 Europe Anesthesia Drugs Sales by Application (2019-2030)
7.2.2 Europe Anesthesia Drugs Revenue by Application (2019-2030)
7.3 Europe Anesthesia Drugs Market Size by Country
7.3.1 Europe Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Anesthesia Drugs Revenue by Country (2019-2030)
7.3.3 Europe Anesthesia Drugs Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Anesthesia Drugs Market Size by Type
8.1.1 China Anesthesia Drugs Sales by Type (2019-2030)
8.1.2 China Anesthesia Drugs Revenue by Type (2019-2030)
8.2 China Anesthesia Drugs Market Size by Application
8.2.1 China Anesthesia Drugs Sales by Application (2019-2030)
8.2.2 China Anesthesia Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Anesthesia Drugs Market Size by Type
9.1.1 Asia Anesthesia Drugs Sales by Type (2019-2030)
9.1.2 Asia Anesthesia Drugs Revenue by Type (2019-2030)
9.2 Asia Anesthesia Drugs Market Size by Application
9.2.1 Asia Anesthesia Drugs Sales by Application (2019-2030)
9.2.2 Asia Anesthesia Drugs Revenue by Application (2019-2030)
9.3 Asia Anesthesia Drugs Market Size by Region
9.3.1 Asia Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Anesthesia Drugs Revenue by Region (2019-2030)
9.3.3 Asia Anesthesia Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anesthesia Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Anesthesia Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Anesthesia Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Anesthesia Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Anesthesia Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Anesthesia Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Anesthesia Drugs Market Size by Country
10.3.1 Middle East, Africa and Latin America Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Anesthesia Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Anesthesia Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Corporate Profile
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Information
11.1.2 Aspen Pharma Overview
11.1.3 Aspen Pharma Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Aspen Pharma Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aspen Pharma Recent Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Information
11.2.2 Fresenius-Kabi Overview
11.2.3 Fresenius-Kabi Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Fresenius-Kabi Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius-Kabi Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AbbVie Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Baxter Healthcare Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Healthcare Recent Developments
11.5 B.Braun
11.5.1 B.Braun Company Information
11.5.2 B.Braun Overview
11.5.3 B.Braun Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 B.Braun Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B.Braun Recent Developments
11.6 Maruishi
11.6.1 Maruishi Company Information
11.6.2 Maruishi Overview
11.6.3 Maruishi Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Maruishi Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Maruishi Recent Developments
11.7 Piramal
11.7.1 Piramal Company Information
11.7.2 Piramal Overview
11.7.3 Piramal Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Piramal Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hikma Pharmaceuticals Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell Company Information
11.9.2 Yichang Humanwell Overview
11.9.3 Yichang Humanwell Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Yichang Humanwell Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yichang Humanwell Recent Developments
11.10 Nhwa
11.10.1 Nhwa Company Information
11.10.2 Nhwa Overview
11.10.3 Nhwa Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Nhwa Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nhwa Recent Developments
11.11 Hengrui
11.11.1 Hengrui Company Information
11.11.2 Hengrui Overview
11.11.3 Hengrui Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hengrui Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hengrui Recent Developments
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Information
11.12.2 Xi'an Libang Overview
11.12.3 Xi'an Libang Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Xi'an Libang Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Xi'an Libang Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Anesthesia Drugs Industry Chain Analysis
12.2 Anesthesia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anesthesia Drugs Production Mode & Process
12.4 Anesthesia Drugs Sales and Marketing
12.4.1 Anesthesia Drugs Sales Channels
12.4.2 Anesthesia Drugs Distributors
12.5 Anesthesia Drugs Customers

13 Anesthesia Drugs Market Dynamics
13.1 Anesthesia Drugs Industry Trends
13.2 Anesthesia Drugs Market Drivers
13.3 Anesthesia Drugs Market Challenges
13.4 Anesthesia Drugs Market Restraints

14 Key Findings in the Global Anesthesia Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

biaoTi

表と図のリスト

List of Tables
 Table 1. Global Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Propofol
 Table 3. Major Manufacturers of Sevoflurane
 Table 4. Major Manufacturers of Local Anesthesia
 Table 5. Major Manufacturers of Other
 Table 6. Global Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. Global Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Anesthesia Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 9. Global Anesthesia Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 10. Global Anesthesia Drugs Revenue Market Share by Region (2019-2024)
 Table 11. Global Anesthesia Drugs Revenue Market Share by Region (2025-2030)
 Table 12. Global Anesthesia Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
 Table 13. Global Anesthesia Drugs Sales by Region (2019-2024) & (M Units)
 Table 14. Global Anesthesia Drugs Sales by Region (2025-2030) & (M Units)
 Table 15. Global Anesthesia Drugs Sales Market Share by Region (2019-2024)
 Table 16. Global Anesthesia Drugs Sales Market Share by Region (2025-2030)
 Table 17. Global Anesthesia Drugs Sales by Manufacturers (2019-2024) & (M Units)
 Table 18. Global Anesthesia Drugs Sales Share by Manufacturers (2019-2024)
 Table 19. Global Anesthesia Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 20. Global Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
 Table 21. Global Key Players of Anesthesia Drugs, Industry Ranking, 2021 VS 2022 VS 2023
 Table 22. Anesthesia Drugs Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 23. Global Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 24. Global Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anesthesia Drugs as of 2023)
 Table 25. Global Key Manufacturers of Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
 Table 26. Global Key Manufacturers of Anesthesia Drugs, Product Offered and Application
 Table 27. Global Key Manufacturers of Anesthesia Drugs, Date of Enter into This Industry
 Table 28. Mergers & Acquisitions, Expansion Plans
 Table 29. Global Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 30. Global Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 31. Global Anesthesia Drugs Sales Share by Type (2019-2024)
 Table 32. Global Anesthesia Drugs Sales Share by Type (2025-2030)
 Table 33. Global Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 34. Global Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 35. Global Anesthesia Drugs Revenue Share by Type (2019-2024)
 Table 36. Global Anesthesia Drugs Revenue Share by Type (2025-2030)
 Table 37. Anesthesia Drugs Price by Type (2019-2024) & (US$/Unit)
 Table 38. Global Anesthesia Drugs Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 39. Global Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 40. Global Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 41. Global Anesthesia Drugs Sales Share by Application (2019-2024)
 Table 42. Global Anesthesia Drugs Sales Share by Application (2025-2030)
 Table 43. Global Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 44. Global Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 45. Global Anesthesia Drugs Revenue Share by Application (2019-2024)
 Table 46. Global Anesthesia Drugs Revenue Share by Application (2025-2030)
 Table 47. Anesthesia Drugs Price by Application (2019-2024) & (US$/Unit)
 Table 48. Global Anesthesia Drugs Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 49. US & Canada Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 50. US & Canada Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 51. US & Canada Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 52. US & Canada Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 53. US & Canada Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 54. US & Canada Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 55. US & Canada Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 56. US & Canada Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 57. US & Canada Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 58. US & Canada Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 59. US & Canada Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 60. US & Canada Anesthesia Drugs Sales by Country (2019-2024) & (M Units)
 Table 61. US & Canada Anesthesia Drugs Sales by Country (2025-2030) & (M Units)
 Table 62. Europe Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 63. Europe Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 64. Europe Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 65. Europe Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 66. Europe Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 67. Europe Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 68. Europe Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 69. Europe Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 70. Europe Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 71. Europe Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 72. Europe Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 73. Europe Anesthesia Drugs Sales by Country (2019-2024) & (M Units)
 Table 74. Europe Anesthesia Drugs Sales by Country (2025-2030) & (M Units)
 Table 75. China Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 76. China Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 77. China Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 78. China Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 79. China Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 80. China Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 81. China Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 82. China Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 83. Asia Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 84. Asia Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 85. Asia Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 86. Asia Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 87. Asia Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 88. Asia Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 89. Asia Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 90. Asia Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 91. Asia Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 92. Asia Anesthesia Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 93. Asia Anesthesia Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 94. Asia Anesthesia Drugs Sales by Region (2019-2024) & (M Units)
 Table 95. Asia Anesthesia Drugs Sales by Region (2025-2030) & (M Units)
 Table 96. Middle East, Africa and Latin America Anesthesia Drugs Sales by Type (2019-2024) & (M Units)
 Table 97. Middle East, Africa and Latin America Anesthesia Drugs Sales by Type (2025-2030) & (M Units)
 Table 98. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
 Table 99. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
 Table 100. Middle East, Africa and Latin America Anesthesia Drugs Sales by Application (2019-2024) & (M Units)
 Table 101. Middle East, Africa and Latin America Anesthesia Drugs Sales by Application (2025-2030) & (M Units)
 Table 102. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
 Table 103. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
 Table 104. Middle East, Africa and Latin America Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 105. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 107. Middle East, Africa and Latin America Anesthesia Drugs Sales by Country (2019-2024) & (M Units)
 Table 108. Middle East, Africa and Latin America Anesthesia Drugs Sales by Country (2025-2030) & (M Units)
 Table 109. Aspen Pharma Company Information
 Table 110. Aspen Pharma Description and Major Businesses
 Table 111. Aspen Pharma Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 112. Aspen Pharma Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 113. Aspen Pharma Recent Developments
 Table 114. Fresenius-Kabi Company Information
 Table 115. Fresenius-Kabi Description and Major Businesses
 Table 116. Fresenius-Kabi Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 117. Fresenius-Kabi Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 118. Fresenius-Kabi Recent Developments
 Table 119. AbbVie Company Information
 Table 120. AbbVie Description and Major Businesses
 Table 121. AbbVie Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 122. AbbVie Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 123. AbbVie Recent Developments
 Table 124. Baxter Healthcare Company Information
 Table 125. Baxter Healthcare Description and Major Businesses
 Table 126. Baxter Healthcare Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 127. Baxter Healthcare Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 128. Baxter Healthcare Recent Developments
 Table 129. B.Braun Company Information
 Table 130. B.Braun Description and Major Businesses
 Table 131. B.Braun Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 132. B.Braun Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 133. B.Braun Recent Developments
 Table 134. Maruishi Company Information
 Table 135. Maruishi Description and Major Businesses
 Table 136. Maruishi Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 137. Maruishi Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 138. Maruishi Recent Developments
 Table 139. Piramal Company Information
 Table 140. Piramal Description and Major Businesses
 Table 141. Piramal Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 142. Piramal Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 143. Piramal Recent Developments
 Table 144. Hikma Pharmaceuticals Company Information
 Table 145. Hikma Pharmaceuticals Description and Major Businesses
 Table 146. Hikma Pharmaceuticals Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 147. Hikma Pharmaceuticals Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 148. Hikma Pharmaceuticals Recent Developments
 Table 149. Yichang Humanwell Company Information
 Table 150. Yichang Humanwell Description and Major Businesses
 Table 151. Yichang Humanwell Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 152. Yichang Humanwell Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 153. Yichang Humanwell Recent Developments
 Table 154. Nhwa Company Information
 Table 155. Nhwa Description and Major Businesses
 Table 156. Nhwa Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 157. Nhwa Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 158. Nhwa Recent Developments
 Table 159. Hengrui Company Information
 Table 160. Hengrui Description and Major Businesses
 Table 161. Hengrui Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 162. Hengrui Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 163. Hengrui Recent Developments
 Table 164. Xi'an Libang Company Information
 Table 165. Xi'an Libang Description and Major Businesses
 Table 166. Xi'an Libang Anesthesia Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 167. Xi'an Libang Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
 Table 168. Xi'an Libang Recent Developments
 Table 169. Key Raw Materials Lists
 Table 170. Raw Materials Key Suppliers Lists
 Table 171. Anesthesia Drugs Distributors List
 Table 172. Anesthesia Drugs Customers List
 Table 173. Anesthesia Drugs Market Trends
 Table 174. Anesthesia Drugs Market Drivers
 Table 175. Anesthesia Drugs Market Challenges
 Table 176. Anesthesia Drugs Market Restraints
 Table 177. Research Programs/Design for This Report
 Table 178. Key Data Information from Secondary Sources
 Table 179. Key Data Information from Primary Sources


List of Figures
 Figure 1. Anesthesia Drugs Product Picture
 Figure 2. Global Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Anesthesia Drugs Market Share by Type: 2023 & 2030
 Figure 4. Propofol Product Picture
 Figure 5. Sevoflurane Product Picture
 Figure 6. Local Anesthesia Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 9. Global Anesthesia Drugs Market Share by Application: 2023 & 2030
 Figure 10. Injection Anesthetics
 Figure 11. Inhalational Anesthetics
 Figure 12. Other
 Figure 13. Anesthesia Drugs Report Years Considered
 Figure 14. Global Anesthesia Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 16. Global Anesthesia Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 17. Global Anesthesia Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 18. Global Anesthesia Drugs Revenue Market Share by Region (2019-2030)
 Figure 19. Global Anesthesia Drugs Sales (2019-2030) & (M Units)
 Figure 20. Global Anesthesia Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
 Figure 21. Global Anesthesia Drugs Sales Market Share by Region (2019-2030)
 Figure 22. US & Canada Anesthesia Drugs Sales YoY (2019-2030) & (M Units)
 Figure 23. US & Canada Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
 Figure 24. Europe Anesthesia Drugs Sales YoY (2019-2030) & (M Units)
 Figure 25. Europe Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. China Anesthesia Drugs Sales YoY (2019-2030) & (M Units)
 Figure 27. China Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Asia (excluding China) Anesthesia Drugs Sales YoY (2019-2030) & (M Units)
 Figure 29. Asia (excluding China) Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Middle East, Africa and Latin America Anesthesia Drugs Sales YoY (2019-2030) & (M Units)
 Figure 31. Middle East, Africa and Latin America Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Global Anesthesia Drugs Sales Share by Manufacturers (2023)
 Figure 33. The Anesthesia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 34. Global Anesthesia Drugs Revenue Share by Manufacturers (2023)
 Figure 35. The Top 5 and 10 Largest Manufacturers of Anesthesia Drugs in the World: Market Share by Anesthesia Drugs Revenue in 2023
 Figure 36. Global Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 37. Global Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 38. Global Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 39. Global Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 40. Global Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 41. US & Canada Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 42. US & Canada Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 43. US & Canada Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 44. US & Canada Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 45. US & Canada Anesthesia Drugs Revenue Share by Country (2019-2030)
 Figure 46. US & Canada Anesthesia Drugs Sales Share by Country (2019-2030)
 Figure 47. US Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 48. Canada Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 49. Europe Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 50. Europe Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 51. Europe Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 52. Europe Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 53. Europe Anesthesia Drugs Revenue Share by Country (2019-2030)
 Figure 54. Europe Anesthesia Drugs Sales Share by Country (2019-2030)
 Figure 55. Germany Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 56. France Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 57. U.K. Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 58. Italy Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 59. Russia Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 60. China Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 61. China Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 62. China Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 63. China Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 64. Asia Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 65. Asia Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 66. Asia Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 67. Asia Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 68. Asia Anesthesia Drugs Revenue Share by Region (2019-2030)
 Figure 69. Asia Anesthesia Drugs Sales Share by Region (2019-2030)
 Figure 70. Japan Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 71. South Korea Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 72. China Taiwan Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 73. Southeast Asia Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 74. India Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 75. Australia Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 76. Middle East, Africa and Latin America Anesthesia Drugs Sales Market Share by Type (2019-2030)
 Figure 77. Middle East, Africa and Latin America Anesthesia Drugs Revenue Market Share by Type (2019-2030)
 Figure 78. Middle East, Africa and Latin America Anesthesia Drugs Sales Market Share by Application (2019-2030)
 Figure 79. Middle East, Africa and Latin America Anesthesia Drugs Revenue Market Share by Application (2019-2030)
 Figure 80. Middle East, Africa and Latin America Anesthesia Drugs Revenue Share by Country (2019-2030)
 Figure 81. Middle East, Africa and Latin America Anesthesia Drugs Sales Share by Country (2019-2030)
 Figure 82. Brazil Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 83. Mexico Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 84. Turkey Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 85. Israel Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 86. GCC Countries Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
 Figure 87. Anesthesia Drugs Value Chain
 Figure 88. Anesthesia Drugs Production Process
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)